trial · primary record
Adaptive Stereotactic Body Radiation
Neoplasm - Soft Tissue Pelvis Malignant Secondary
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2029-06-01 |
| Primary endpoint | To assess the ability of adaptive SBRT to deliver increased doses of radiation safely to patients with challenging anatomical locations of metastatic disease without causing unacceptable toxicity. |
| Registry ID | NCT05880667 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:34.080Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05880667
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.